1
Clinical Trials associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)Pilot Study of Therapeutic Vaccination by Leukemic Blasts in Vitro Differentiated Dendritic Cells From Patients With Acute Myelogenous Leukemia in Complete Remission
RATIONALE: Vaccines made from dendritic cells may help the body build an effective immune response to kill cancer cells.
PURPOSE: This phase I trial is studying the side effects of vaccine therapy and to see how well it works in treating patients with acute myeloid leukemia in complete remission.
100 Clinical Results associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Translational Medicine associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Patents (Medical) associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Deals associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)